Digital Symptom Check-Ins Show Promise for Cancer Patients

A clinical study published in JCO Oncology Practice reveals that weekly electronic symptom check-ins significantly improve quality of life for patients with advanced cancer. The PRO-TECT trial, involving nearly 1,200 participants, demonstrates that these digital interventions effectively bridge communication gaps, particularly benefiting underserved groups and reducing emergency department visits.

The PRO-TECT Trial: Methodology and Reach

The PRO-TECT study, supported by the Alliance Foundation Trials (AFT), sought to evaluate whether routine, remote monitoring could mitigate the challenges patients face during treatment for metastatic solid tumors. Researchers randomly assigned 1,191 adult patients to either a standard care group or an intervention group that completed weekly electronic symptom surveys. These check-ins were designed to be accessible, allowing participants to report their status via the internet or an automated telephone system that required no web access.

When a patient reported symptoms that crossed a predetermined severity threshold, the system automatically alerted a nurse on their clinical care team and provided the patient with self-management materials. This feedback loop proved highly active, with 41% of all submitted reports triggering an automated alert to medical staff.

Measurable Gains in Symptom Control and Physical Function

The results at the three-month mark showed a clear divergence between those receiving remote monitoring and those in the standard care group. Patients using the digital check-in system reported a mean 2.37-point improvement in symptom control and a 1.54-point improvement in physical function. Conversely, the usual care group experienced declines in both metrics.

ACCC Recognizes Ethan Basch on Symptom Monitoring in Oncology

Study chair Ethan Basch, MD, of the UNC Lineberger Comprehensive Cancer Center, noted that these differences were not only statistically significant but also clinically meaningful. Beyond the immediate scoring improvements, the researchers observed substantial delays until symptom worsening among the intervention group. Despite these positive findings, Basch cautioned that the field is still in an early phase, noting that many medical practices are currently in the process of learning how to best integrate this patient-centered technology into their existing workflows.

Bridging Disparities for Underserved Patient Populations

One of the most notable findings of the PRO-TECT trial is the outsized benefit observed among patient groups that have historically faced barriers to healthcare access. Data from the study indicate that Black patients, younger patients, women, and individuals with a high school education or less experienced the most significant quality-of-life gains.

For Black patients, the intervention effectively closed a baseline gap in symptom control, bringing their outcomes on par with White patients by the third month of the study. Allison Deal, a senior biostatistician at the UNC Lineberger Comprehensive Cancer Center, emphasized that the system helps bypass common hurdles like communication gaps or clinician bias, allowing patient concerns to move directly to the medical team for quick intervention.

Broader Context of Cancer Care Inequality

The success of this remote monitoring approach arrives against a backdrop of persistent inequality in oncology outcomes. Data from the American Association for Cancer Research (AACR) highlight significant survival disparities, noting that between 2014 and 2020, racial and ethnic minority groups consistently showed lower five-year relative survival rates compared to non-Hispanic White patients. Furthermore, mortality rates for Black men and women remained notably higher in the 2016–2020 period.

While the study suggests that digital tools can act as a could be a game-changer for lowering healthcare disparities and ensuring every cancer patient gets the responsive care they need. the researchers acknowledge that widespread adoption is still a work in progress. With more than 80 health systems across the U.S. currently implementing some form of patient-reported outcome monitoring, the focus is shifting toward how these systems can be scaled to ensure consistent, responsive care for all patients, regardless of their background or socioeconomic status.

Find more reporting in our Health section.

Keep reading